首页|microRNA-338-3p抑制HepG2肝癌细胞的迁移和侵袭

microRNA-338-3p抑制HepG2肝癌细胞的迁移和侵袭

扫码查看
目的 研究microRNA-338-3p对HepG2 肝癌细胞迁移、侵袭和上皮间质转化的影响.方法 取HepG2 肝癌细胞,随机分为三组:control组(未转染)、vector组(转染空质粒)、OE组(转染microRNA-338-3p质粒),分别取生理盐水、空质粒、microRNA-338-3p转染,培养 48 小时.实时荧光定量PCR(qPCR)检测microRNA-338-3p的转染效率;划痕实验检测细胞的迁移指数;Transwell法检测细胞的侵袭能力;蛋白质印迹法(Western blot实验)检测细胞E-cadherin、N-cadherin的相对蛋白表达量.结果 (1)microRNA-338-3p 的转染阳性率超过 90%,符合实验标准.(2)HepG2 肝癌细胞的迁移指数,control组与vector组相比较,差异无统计学意义(P>0.05);OE组与control组、vec-tor组相比较,迁移指数明显降低,差异有统计学意义(P<0.01).(3)HepG2 肝癌细胞的侵袭能力,control组与vector组相比较,差异无统计学意义(P>0.05);OE组HepG2 与control组、vector组相比较,侵袭能力显著下降,差异有统计学意义(P<0.001).(4)E-cadherin相对蛋白表达量,control组与vector组相比较,差异无统计学意义(P>0.05);OE组与control组、vector组相比较,E-cadherin相对蛋白表达量均增高,差异有统计学意义(P<0.05).(5)N-cadherin的相对蛋白表达量,control组与vector组相比较,差异无统计学意义(P>0.05);OE组与control组、vector组相比较,N-cadherin相对蛋白表达量减少,差异均有统计学意义(P<0.01).结论 (1)microRNA-338-3p可抑制HepG2 肝癌细胞的迁移、侵袭能力;(2)microRNA-338-3p 通过促进 E-cadherin 蛋白表达并抑制 N-cadherin 蛋白表达,从而抑制HepG2 肝癌细胞的上皮间质转化.
Inhibition of microRNA-338-3p on migration and invasion of HepG2 hepatoma cells
Objective To investigate the effects of microRNA-338-3p on migration,invasion and epithelial mesenchymal transformation of HepG2 hepatoma cells.Methods HepG2 hepatoma cells were extracted.They were randomly divided into three groups:control group(non-transfected),vector group(transfected with empty plasmid)and OE group(transfected with microRNA-338-3p plasmid).Normal saline,empty plasmid and microRNA-338-3p were transfected,respectively,and cultured for 48 hours.Real-time fluorescence quantitative PCR(qPCR)was used to detect the transfection efficiency of mi-croRNA-338-3p.The migration index of cells was detected by scratch test.The invasive ability of cells was detected by Tran-swell method.The relative protein expression levels of E-cadherin and N-cadherin were detected by Western blot assay.Results(1)The positive rate of microRNA-338-3p transfection in this study was over 90%,which met the experimental criteria.(2)The migration index of HepG2 liver cancer cells showed no statistically significant difference between the con-trol group and the vector group(P>0.05).The migration index of the OE group was significantly lower than that of the con-trol group and the vector group,and difference was statistically significant(P<0.01).(3)There was no statistically signifi-cant difference in the invasion ability of HepG2 hepatocellular carcinoma cells in the control group and the vector group(P>0.05);compared with the control group and the vector group,the invasion ability of HepG2 in the OE group significantly de-creased,and the difference was statistically significant(P<0.001).(4)There was no statistically significant difference in the relative protein expression of E-cadherin between the control group and the vector group(P>0.05);the relative protein expression of E-cadherin in the OE group was higher than that in the control group and the vector group,and the difference was statistically significant(P<0.05).(5)There was no statistically significant difference in the relative protein expression of N-cadherin between the control group and the vector group(P>0.05);compared with the control group and the vector group,the relative protein expression of N-cadherin decreased in the OE group,and the difference was statistically significant(P<0.01).Conclusion(1)microRNA-338-3p can inhibit the migration and invasion ability of HepG2 liver cancer cells;(2)microRNA-338-3p inhibits epithelial mesenchymal transition in HepG2 liver cancer cells by promoting E-cadherin pro-tein expression and inhibiting N-cadherin protein expression.

microRNAhepatocellular carcinomamigrationinvasion

念家辉、韦卿、刘国满、黄梓华、黄理政、浦涧

展开 >

右江民族医学院附属医院肝胆外科,广西百色 533000

右江民族医学院研究生学院,广西百色 533000

微小RNA 肝细胞癌 迁移 侵袭

广西自然科学基金

2020GXNSFAA259019

2024

右江医学
右江民族医学院附属医院

右江医学

影响因子:0.779
ISSN:1003-1383
年,卷(期):2024.52(3)
  • 9